Cardio Diagnostics (CDIO) vs Dermata Therapeutics (DRMA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Cardio Diagnostics is the larger company by market cap ($5.5 million vs $5.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDIO | DRMA |
|---|---|---|
| Share price | $1.86 | $1.07 |
| Market cap | $5.50M | $5.30M |
| 1-day change | -5.58% | -4.46% |
| EPS (TTM) | $-2.91 | $-4.39 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.91 | $4.66 |
| 52-week low | $0.97 | $0.951 |
| Distance from 52-week high | -76.49% | -77.04% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +273.83% |
| Average volume | 56.01K | 706.43K |
| Shares outstanding | 2.96M | 4.96M |
| Employees | 15 | 9 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cardio Diagnostics
CDIO stock →Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease.
Healthcare · Biotechnology · 15 employees
About Dermata Therapeutics
DRMA stock →Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States.
Healthcare · Biotechnology · 9 employees
CDIO vs DRMA FAQ
Which is bigger, Cardio Diagnostics or Dermata Therapeutics?
Cardio Diagnostics (CDIO) is larger, with a market capitalization of $5.50M compared with $5.30M for Dermata Therapeutics (DRMA).
Are Cardio Diagnostics and Dermata Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.